Bactericidal activity of BMY-28100 versus amoxicillin/clavulanic acid against Branhamella catarrhalis.

Suppr

超能文献

作者信息

Yourassowsky E, Van der Linden M P, Lismont M J, Crokaert F

机构信息

Department of Microbiology, Brugman University Hospital, Brussels, Belgium.

出版信息

Eur J Clin Microbiol Infect Dis. 1988 Jun;7(3):433-4. doi: 10.1007/BF01962359.

DOI:10.1007/BF01962359

PMID:3137055

Abstract

摘要

相似文献

Bactericidal activity of BMY-28100 versus amoxicillin/clavulanic acid against Branhamella catarrhalis.

Eur J Clin Microbiol Infect Dis. 1988 Jun;7(3):433-4. doi: 10.1007/BF01962359.

Rate of bactericidal activity for Branhamella catarrhalis of a new macrolide, CP-62,993, compared with that of amoxicillin-clavulanic acid.

Chemotherapy. 1988;34(3):191-4. doi: 10.1159/000238570.

Rate of bactericidal activity for Branhamella catarrhalis of fleroxacin compared with that of amoxycillin-clavulanic acid.氟罗沙星对卡他莫拉菌的杀菌活性速率与阿莫西林-克拉维酸的比较。

J Antimicrob Chemother. 1988 Oct;22 Suppl D:43-7. doi: 10.1093/jac/22.supplement_d.43.

In vitro activity of BAY v 3522, a new oral cephalosporin tested against Haemophilus influenzae and Branhamella catarrhalis.新型口服头孢菌素BAY v 3522针对流感嗜血杆菌和卡他布兰汉菌的体外活性

Diagn Microbiol Infect Dis. 1990 Jul-Aug;13(4):349-52. doi: 10.1016/0732-8893(90)90030-y.

In vitro activity of ceftibuten against Haemophilus influenzae and Branhamella catarhallis.头孢布烯对流感嗜血杆菌和卡他布兰汉菌的体外活性。

Diagn Microbiol Infect Dis. 1991 Jan-Feb;14(1):75-7. doi: 10.1016/0732-8893(91)90092-t.

Killing kinetics of five orally administered antibiotics at clinically achievable concentrations against Moraxella catarrhalis.

Eur J Clin Microbiol Infect Dis. 1992 Oct;11(10):923-6. doi: 10.1007/BF01962375.

Effect of low concentrations of clavulanic acid on the in-vitro activity of amoxycillin against beta-lactamase-producing Branhamella catarrhalis and Haemophilus influenzae.低浓度克拉维酸对阿莫西林体外抗产β-内酰胺酶卡他莫拉菌和流感嗜血杆菌活性的影响。

J Antimicrob Chemother. 1990 Sep;26(3):371-80. doi: 10.1093/jac/26.3.371.

Exacerbation of COPD: amoxicillin + clavulanic acid in vitro activity vs S. pneumoniae, H. influenzae and M. catarrhalis.慢性阻塞性肺疾病急性加重期：阿莫西林+克拉维酸对肺炎链球菌、流感嗜血杆菌和卡他莫拉菌的体外活性

J Chemother. 1995 Nov;7 Suppl 4:61-2.

[Branhamella catarrhalis: incidence in pulmonary infections and determination of sensitivity to 5 antibiotics].[卡他布兰汉菌：肺部感染中的发病率及对5种抗生素的敏感性测定]

Pathol Biol (Paris). 1988 May;36(5):540-3.

In vitro activity of cefdinir against respiratory pathogens isolated in Sicily with reference to beta-lactamase production.头孢地尼对西西里岛分离出的呼吸道病原体的体外活性及β-内酰胺酶产生情况

J Chemother. 1996 Jun;8(3):193-9. doi: 10.1179/joc.1996.8.3.193.

引用本文的文献

Branhamella catarrhalis: an organism gaining respect as a pathogen.卡他布兰汉菌：一种日益受到重视的病原菌。

Clin Microbiol Rev. 1990 Oct;3(4):293-320. doi: 10.1128/CMR.3.4.293.

本文引用的文献

Comparative in vitro activity of the new oral cephalosporin BMY-28100.新型口服头孢菌素BMY-28100的体外活性比较

Eur J Clin Microbiol. 1987 Apr;6(2):170-2. doi: 10.1007/BF02018202.

Comparative antibacterial activity of the new oral cephalosporin BMY-28100.新型口服头孢菌素BMY-28100的抗菌活性比较

Eur J Clin Microbiol. 1987 Jun;6(3):309-12. doi: 10.1007/BF02017621.

The incidence and antibiotic susceptibility of Branhamella catarrhalis in respiratory infections.卡他布兰汉菌在呼吸道感染中的发病率及抗生素敏感性

Drugs. 1986;31 Suppl 3:11-6. doi: 10.2165/00003495-198600313-00005.

BMY 28100, a new oral cephalosporin.BMY 28100，一种新型口服头孢菌素。

Antimicrob Agents Chemother. 1987 Feb;31(2):238-43. doi: 10.1128/AAC.31.2.238.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验